Recognizing the urgent need for treatment options and guided by patient insights, Pfizer scientists have discovered a way to ...

Prophylactic use of filgrastim at nadir: Impact of haematological parameters on recovery of grade IV neutropenia induced by standard dose chemotherapy No significant financial relationships to ...

Eating disorders are often thought of as body image disorders with symptoms of food restriction and purging. In most cases, the goal of these behaviors is to prevent weight gain. Not all eating ...

Researchers at the University of Houston are pushing the boundaries of biomedical innovation with a discovery that could ...

Cancer patients often lose excessive amounts of weight. This affects up to 80% of patients and is mainly due to a decrease in ...

Andrew Joseph covers health, medicine, and the biopharma industry in Europe. You can reach Andrew on Signal at drewqjoseph.45. BARCELONA, Spain — Patients with advanced cancers often develop a ...

Sept. 14 (UPI) --A drug that could reduce the risk of death in cancer patients is showing good promise during its second phase of clinical tests, drugmaker Pfizer announced Saturday. The experimental ...

Please provide your email address to receive an email when new articles are posted on . Patients with cancer cachexia assigned ponsegromab gained significantly more weight than those assigned placebo.

PH284 nasal spray increased hunger in cancer cachexia patients, showing a 71% improvement in subjective hunger scores compared to baseline. The phase 2A study demonstrated PH284's safety, with no ...